NGS testing is ideally ordered at diagnosis of advanced or metastatic disease, before starting systemic therapy, so results can guide first-line treatment selection. It’s also valuable at disease progression or when resistance develops, to identify new actionable alterations and inform the next line of therapy.
No results found!